Stockscreener 앱 받기
2.65
5.36%
-0.15
시간 외 거래:
2.64
-0.010
-0.38%
Oncology Institute Inc 주식(TOI)의 최신 뉴스
The Oncology Institute, Inc.'s (NASDAQ:TOI) largest shareholders are retail investors with 40% ownership, private equity firms own 24% - Yahoo Finance
The Oncology Institute, Inc. (NASDAQ:TOI) Shares Sold by Geode Capital Management LLC - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
New Outlook On Oncology Institute Inc - Stocksregister
Oncology Institute Inc [TOI] Records 50-Day SMA of $1.38 - knoxdaily.com
A new trading data show Oncology Institute Inc (TOI) is showing positive returns. - Sete News
Closing Strong: Oncology Institute Inc (TOI) Ends at 2.50, Down -14.09 from Last Close - DWinneX
Why The Oncology Institute, Inc. (TOI) is Surging in 2025 - Insider Monkey
Oncology Institute Inc Inc. (TOI) Price Performance: A Comparative Analysis with Competitors - investchronicle.com
Oncology Institute Inc (TOI)’s highs and lows: A closer look at its stock price fluctuations - uspostnews.com
Jefferies gives a Buy recommendation for Oncology Institute Inc (TOI) - knoxdaily.com
Oncology Institute Inc [TOI] Records 50-Day SMA of $1.19 - knoxdaily.com
Take off with Oncology Institute Inc (TOI): Get ready for trading - Sete News
Major Blood Cancer Center Joins CERo's Novel AML Treatment Trial, June Dosing Planned - Stock Titan
Stock Performance Spotlight: Oncology Institute Inc (TOI) Ends the Day at 2.88, Up by 6.27 - DWinneX
Oncology Institute (NASDAQ:TOI) Trading 6.3% Higher – Still a Buy? - The AM Reporter
Oncology Institute (NASDAQ:TOI) Stock Price Up 6.3% – Still a Buy? - Defense World
The Oncology Institute Reports Third Quarter 2024 Financial Results - ADVFN
The Oncology Institute Announces First Quarter 2025 Earnings Release Date and Conference Call - The Manila Times
Leading US Oncology Group TOI Readies Q1 2025 Financial Results: Key Details for May 14 Earnings Call - Stock Titan
The Oncology Institute Expands Partnership with Helios Clinical Research to Enhance Access to Clinical Trials - Nasdaq
The Oncology Institute of Hope and Innovation Expands - GlobeNewswire
Major Breakthrough: Cancer Care Provider TOI Rolls Out Nationwide Clinical Trial Access Program - Stock Titan
A Tale of Resilience: Oncology Institute Inc Amid Stock Market Turbulence - investchronicle.com
Why Acquire Shares Of Oncology Institute Inc (TOI)? - Marketing Sentinel
The Oncology Institute Reports Fourth Quarter and Full Year 2024 Financial Results and Guidance for 2025 - ADVFN
The Oncology Institute Announces $16.5 million Private Placement - ADVFN
A Piece Of The Puzzle Missing From The Oncology Institute, Inc.'s (NASDAQ:TOI) 161% Share Price Climb - simplywall.st
Oncology Institute regains Nasdaq compliance with bid price By Investing.com - Investing.com South Africa
Oncology Institute regains Nasdaq compliance with bid price - Investing.com
A Data-Based Look At Oncology Institute Inc (TOI) - stocksregister.com
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Informs Shareholders of an Investigation into The Oncology Institute, Inc. - ACCESS Newswire
Virtu Financial LLC Takes $41,000 Position in The Oncology Institute, Inc. (NASDAQ:TOI) - Defense World
The Oncology Institute, Inc. (TOI): Among Stocks Insiders Were Buying In Q1 2025 - Yahoo Finance
TOI Launches Florida Oncology Network, a Fully Delegated - GlobeNewswire
The Oncology Institute announces launch of the Florida Oncology Network - TipRanks
Healthcare Expansion: TOI Unveils Florida Cancer Network, Secures 80K Patient Contracts - Stock Titan
The oncology institute targets profitability and $460M-$480M revenue in 2025 - MSN
Oncology institute CEO acquires $23,584 in stock By Investing.com - Investing.com Australia
Oncology institute’s chief medical officer buys $9,433 in stock By Investing.com - Investing.com Canada
Oncology Institute Executives Make Bold Moves with Major Stock Purchases - TipRanks
Oncology institute director Karen Johnson acquires $37,734 in shares By Investing.com - Investing.com South Africa
Oncology institute’s COO Jeremy Castle makes $9,433 stock purchase By Investing.com - Investing.com Canada
Oncology institute director Brad Hively acquires $9,433 in stock By Investing.com - Investing.com South Africa
Oncology institute director Mark Pacala acquires $94,338 in stock By Investing.com - Investing.com South Africa
Oncology institute’s chief medical officer buys $9,433 in stock - Investing.com India
Oncology institute director Mark Pacala acquires $94,338 in stock - Investing.com India
Oncology institute’s COO Jeremy Castle makes $9,433 stock purchase - Investing.com
Oncology Institute Executives Make Significant Stock Purchases - TradingView
Oncology institute director Karen Johnson acquires $37,734 in shares - Investing.com
Oncology institute CFO Robert Ross buys $9,433 in stock - Investing.com India
0.26%
0.42%
자본화:
|
볼륨(24시간):